oxazepam has been researched along with Central Hypothyroidism in 3 studies
Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect of severe hypothyroidism on the pharmacokinetics and pharmacodynamics of oxazepam 15 mg given orally (n = 10) and the metabolism of paracetamol 750 mg given intravenously (n = 8) was investigated before and after treatment with levothyroxine." | 7.68 | Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism. ( Andreasen, F; Boesgaard, S; Døssing, M; Hansen, JM; Loft, S; Poulsen, HE; Sonne, J, 1990) |
| " The effect of severe hypothyroidism on the pharmacokinetics and pharmacodynamics of oxazepam 15 mg given orally (n = 10) and the metabolism of paracetamol 750 mg given intravenously (n = 8) was investigated before and after treatment with levothyroxine." | 3.68 | Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism. ( Andreasen, F; Boesgaard, S; Døssing, M; Hansen, JM; Loft, S; Poulsen, HE; Sonne, J, 1990) |
| "The pharmacokinetics of oxazepam, a drug mainly eliminated by a single step glucuronidation reaction, were studied in seven hyperthyroid and six hypothyroid patients before and after treatment." | 3.67 | Oxazepam pharmacokinetics in thyroid disease. ( Bewsher, PD; Hawksworth, GM; Khir, AS; Scott, AK, 1984) |
| " It was a prerequisite to establish the bioavailability of oxazepam prior to succeeding studies on the oral disposition of the drug." | 2.38 | Factors and conditions affecting the glucuronidation of oxazepam. ( Sonne, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scott, AK | 1 |
| Khir, AS | 1 |
| Bewsher, PD | 1 |
| Hawksworth, GM | 1 |
| Sonne, J | 2 |
| Boesgaard, S | 1 |
| Poulsen, HE | 1 |
| Loft, S | 1 |
| Hansen, JM | 1 |
| Døssing, M | 1 |
| Andreasen, F | 1 |
1 review available for oxazepam and Central Hypothyroidism
| Article | Year |
|---|---|
Factors and conditions affecting the glucuronidation of oxazepam.
Topics: Acetaminophen; Age Factors; Aged; Aged, 80 and over; Biological Availability; Biotransformation; Die | 1993 |
2 other studies available for oxazepam and Central Hypothyroidism
| Article | Year |
|---|---|
Oxazepam pharmacokinetics in thyroid disease.
Topics: Adult; Bilirubin; Female; Glucuronosyltransferase; Humans; Hyperthyroidism; Hypothyroidism; Kinetics | 1984 |
Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.
Topics: Acetaminophen; Administration, Oral; Adult; Aged; Female; Humans; Hypothyroidism; Infusions, Intrave | 1990 |